Vaccinology

Research Frontiers in Invariant Natural Killer T Cell Agonist Vaccines

Designing vaccine formulations incorporating alpha-galactosylceramide analogs to activate iNKT cells as potent adjuvant effectors.

All Vaccinology PhD categories